Showing results (131-140 of 675) with videos related to
Sort By:
Pageof 68
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2014
Genetic/familial high-risk assessment: breast and ovarian, version 1.2014Mary B Daly, Robert Pilarski, Jennifer E Axilbund, et al.NPJ Breast Cancer|June 27, 2017
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer riskThomas P Slavin, Kara N Maxwell, Jenna Lilyquist, et al.Cancer|February 8, 2017
Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinomaRyan P Kopp, Kelly L Stratton, Emily Glogowski, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2003
TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studiesVirginia G Kaklamani, Nanjiang Hou, Yiansong Bian, et al.The American Journal of Surgical Pathology|December 23, 2004
Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasmsJinru Shia, David S Klimstra, Khedoudja Nafa, et al.Familial Cancer|March 12, 2013
Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancerShaheen Alanee, Sohela Shah, Joseph Vijai, et al.JAMA Oncology|February 13, 2016
BRCA1 and BRCA2 Mutation Testing in Young Women With Breast CancerShoshana M Rosenberg, Kathryn J Ruddy, Rulla M Tamimi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2007
Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reductionMichael J Callahan, Christopher P Crum, Fabiola Medeiros, et al.Journal of Community Genetics|November 20, 2017
A comparison of cancer risk assessment and testing outcomes in patients from underserved vs. tertiary care settingsHuma Q Rana, Sarah R Cochrane, Elaine Hiller, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 2, 2017
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017Mary B Daly, Robert Pilarski, Michael Berry, et al.Pageof 68